Search

everythinglearnresearchcommunity

for

Search:↓

GnRH analogue can help diagnose ovarian causes of high testosterone in postmenopausal women when scans don't show the cause.

GnRH agonists can help manage recurrent priapism in sickle cell patients, but long-term safety is unclear.

Metformin can start ovulation and may lower 17P response in PCOS, but six months is too short to improve hair growth or change body fat distribution.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

The oral contraceptive alone is the preferred treatment for hirsutism, as adding the GnRH analog showed no significant benefit.

The nafarelin test can reliably distinguish between gonadotropin deficiency and delayed puberty in teenage boys.

GnRH treatment can reduce breast cancer cell invasion.

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.

Dihydrotestosterone changes some hormone-related gene expressions in rat pituitary glands but doesn't affect the estrous cycle.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

The document explains how male reproductive hormones work and affect the body.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Deslorelin can help control reproduction and improve hair growth in German Spitz dogs.

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

A pineal tumor caused a boy's early puberty, which changed from peripheral to central after treatment.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

A new model helps predict treatment success in girls with early puberty.

GnRH-a or orchiectomy is more effective than anti-androgens for managing hormone levels in transgender women.

Different drugs are used to manage breeding, prevent or end pregnancy, and treat reproductive issues in dogs and cats.

Chronic GnRHa treatment can help manage endometrial hyperplasia and reduce ovarian androgen excess in PCO patients.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Some medications can reduce excessive hair growth in women, but more research is needed to find the best treatment combinations.

Most patients improved with oral contraceptives, but some needed additional treatment.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

Low prolactin levels in PCOS can cause metabolic problems like insulin resistance and obesity.